Credit Suisse’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-132
| Closed | -$35K | – | 3568 |
|
|
2016
Q4 | $35K | Sell |
132
-1,160
| -90% | -$308K | ﹤0.01% | 3686 |
|
|
2016
Q3 | $512K | Sell |
1,292
-69
| -5% | -$27.3K | ﹤0.01% | 3075 |
|
|
2016
Q2 | $471K | Buy |
1,361
+180
| +15% | +$62.3K | ﹤0.01% | 3160 |
|
|
2016
Q1 | $982K | Sell |
1,181
-14
| -1% | -$11.6K | ﹤0.01% | 2464 |
|
|
2015
Q4 | $1.25M | Buy |
1,195
+74
| +7% | +$77.4K | ﹤0.01% | 2439 |
|
|
2015
Q3 | $879K | Sell |
1,121
-1,043
| -48% | -$818K | ﹤0.01% | 2739 |
|
|
2015
Q2 | $2.85M | Buy |
2,164
+703
| +48% | +$925K | ﹤0.01% | 2047 |
|
|
2015
Q1 | $2.97M | Buy |
1,461
+226
| +18% | +$459K | ﹤0.01% | 1862 |
|
|
2014
Q4 | $2.38M | Buy |
+1,235
| New | +$2.38M | ﹤0.01% | 2104 |
|
|
2014
Q3 | – | Sell |
-125
| Closed | -$120K | – | 4151 |
|
|
2014
Q2 | $120K | Sell |
125
-24
| -16% | -$23K | ﹤0.01% | 4076 |
|
|
2014
Q1 | $161K | Sell |
149
-40
| -21% | -$43.2K | ﹤0.01% | 4041 |
|
|
2013
Q4 | $168K | Buy |
189
+104
| +122% | +$92.4K | ﹤0.01% | 3927 |
|
|
2013
Q3 | $96K | Buy |
85
+1
| +1% | +$1.13K | ﹤0.01% | 3678 |
|
|
2013
Q2 | $99K | Buy |
+84
| New | +$99K | ﹤0.01% | 3616 |
|